Doug Jermasek

Doug Jermasek

Executive VP, Corporate StrategyatUnicycive Therapeutics· In proxies 2022–2025

Pay in FY2025-45% from the year before · Unicycive Therapeutics stock -27.3% the same year

Doug Jermasek was paid $481.2K in FY2025 (Dec), down 45%. Unicycive Therapeutics stock fell 27.3% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Unicycive Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Unicycive TherapeuticsPublic company · 4 yr
    • Executive VP, Corporate Strategy2022 – Present · 4 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?